Yearly Archives: 2024

The Chancellor announced her Autumn Budget today (30th October), setting out the Government’s overarching spending plans for the next 18 months. The Budget promised an additional £22.6 billion for day-to-day healthcare spending, but the Chancellor made no specific pledges about supporting primary care or the community pharmacy sector. The Chancellor announced a number of changes [...]

The post Chancellor sets out Autumn Budget appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/10/2024) announced the following final list of price concessions for October 2024: Drug Pack size Price concession Amantadine 100mg capsules 56 £17.66 Apixaban 2.5mg tablets 60 £7.21 Apixaban [...]

The post October 2024 Price Concessions Final Update appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 November 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – November 2024 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Aqueous cream 100 £1.11 Clarithromycin 125mg/5ml oral suspension 70 £4.72 Clotrimazole 500mg [...]

The post October 2024 Price Concessions – 3rd Update appeared first on Community Pharmacy England.

Update 31/10/204 – This recall notification has been updated since its initial publication on 29 October 2024 to include the correct description for Labetalol 200mg Tablets. Tillomed Laboratories Limited erroneously provided incorrect information pertaining the description and have ensured that all other information is correct. Please ensure that appropriate action is taken. Drug alert number: [...]

The post MHRA Class 2 Medicines Recall: Labetalol 200mg Tablets (Tillomed Laboratories Limited) – Update appeared first on Community Pharmacy England.